Urothelial carcinoma
Conditions
Interventions
Patients with urothelial carcinoma undergoing endoscopic cryoablation therapy:NA
Patients with urothelial carcinoma undergoing routine surgical treatment:NA
Sponsors
Department of Urology, Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) From January 2019 to May 2024, the patient was clinically diagnosed as bladder cancer or renal pelvis and ureter cancer in Huashan Hospital affiliated to Fudan University; (2) The patient's histological diagnosis is urothelial carcinoma (allowing for any percentage of histological variation); (3) Age range: 18-85 years old, male or female not limited; (4) Patients participating in clinical trials (provided that the trial results have been published), patients receiving treatment according to standard treatment procedures, and patients receiving combination therapy using endoscopic cryoablation are all included in the study scope;
Exclusion criteria
Exclusion criteria: (1) The patient did not receive surgical treatment; (2) The patient's clinical and pathological data is incomplete; (3) The patient refused to use their own clinical data for the analysis of this clinical study; (4) The patient's postoperative pathology ruled out the diagnosis of urothelial carcinoma; (5) Researchers believe that there are other situations that are not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival of 2 years; | — |
Secondary
| Measure | Time frame |
|---|---|
| progression free survival of 2 years;Incidence of postoperative adverse events;Quality of life score;Quality-adjusted life years; | — |
Countries
China
Contacts
Public ContactHaowen Jiang
Fudan University Affiliated Huashan Hospital
Outcome results
None listed